Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

Circulation

Volumn 94, Issue 9, 1996, Pages 2221-2227

  Levine, Ronald L ^a   Chen, Shi Juan ^a   Durand, Joan ^a   Chen, Yiu Fai ^a   Oparil, Suzanne ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b 1034 Zeigler Research Bldg   (United States)

Author keywords

carotid arteries; hormones; restenosis; vasculature; women

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY OBSTRUCTION; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; GROWTH INHIBITION; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; VASCULAR ENDOTHELIUM;

EID: 0029851203     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.9.2221     Document Type: Article

References (43)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809. Review.
2. Stamler J, Pick R, Katz LN. Prevention of coronary atherosclerosis by estrogen-androgen administration in the cholesterol-fed chick. Circ Res. 1953;1:94-98.
3. Foegh M, Asotra S, Howell M, Ramwell P. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1994;19:722-726.
4. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995;96:2482-2488.
5. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577-584.
6. Levine RL, Chen SJ, Durand J, Chen YF, Oparil S. 17β-Estradiol but not medroxyprogesterone inhibits neointima formation after balloon injury of rat carotid arteries. J Invest Med. 1996;44:26A. Abstract.
7. Levine RL, Anderson PG, Lyle K, Yadav SS, Oparil S, Roubin GS. 17β-Estradiol inhibits restenosis after coronary angioplasty in pigs. J Invest Med. 1996;44:26A. Abstract.
8. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res. 1993;73:792-796.
9. PEPI Trial Writing Group. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA. 1995;3:199-208.
10. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
11. Adams MR, Golden DL. Atheroprotective effects of estrogen replacement therapy are antagonized by medroxyprogesterone acetate in monkeys. Circulation. 1995;92(suppl I):I-627, Abstract.
12. Legan SJ, Coon GA, Karsch FJ. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology. 1975;96:50-56.
13. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343:269-270.
14. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab. 1983;57:262-267.
15. Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem. 1979;254:1367-1373.
16. Ma PTS, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc Natl Acad Sci U S A. 1986;83:792-796.
17. Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morrisett JO, Meschia M, Crosignani P. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med. 1993;153:1462-1468.
18. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17β-estradiol. Metabolism. 1992:41:1110-1114.
19. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1111-1119.
20. Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT Jr, Weiss NS, Wagner EH, Prentice R, Furberg CD. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993;153:1421-1427.
21. Tikkanen MJ, Kuusi T, Nikkila EA, Sipinen S. Post-menopausal hormone replacement therapy: effects of progesrogens on serum lipids and lipoproteins: a review. Maturitas. 1986;8:7-17.
22. Newnham HH. Oestrogens and atherosclerotic vascular disease: lipid factors. Baillieres Clin Endocrinol Metab. 1993;7:61-93.
23. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
24. Miller VT. Dyslipoproteinemia in women: special considerations. Endocrinol Metab Clin North Am. 1990;19:381-398.
25. Rijpkema AH, van der Sanden AA, Ruijis AH. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas. 1990;12:259-285.
26. Lobo RA, Pickar JH, Wild RA, Walsh B, Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol. 1994;84:987-995.
27. Kushwaha RS, Lewis DS, Carey KD, McGill HC Jr. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.).Arterioscler Thromb. 1991;11:23-31.
28. Gebara OCE, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PWF, Levy D, Muller JE, Tofler GH. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995;91:1952-1958.
29. Hough JL, Zilversmit DB. Effect of 17-beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986;6:57-63.
30. Adams MR, Rudel LL, Clarkson TB, Nelson CA, Thau RB, Moo-Young AJ. Influence of a levonorgestrel-containing contraceptive vaginal ring on plasma lipids and lipoproteins in cynomolgus monkeys. Contraception. 1983;28:253-266.
31. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
32. Wolinsky H. Effects of estrogen and progestogen treatment on the response of the aorta of male rats to hypertension. Circ Res. 1972;30:341-349.
33. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
34. Adams MR, Clarkson RB, Koritnik DR, Nash HA. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril. 1987;47:1010-1018.
35. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol. 1990;75:217-222.
36. Adams MR, Golden DL. Atheroprotective effects of estrogen replacement therapy are antagonized by medroxyprogesterone acetate in monkeys. Circulation. 1995;92(suppl I):I-8. Abstract.
37. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest. 1982;69:750-758.
38. Kraus WL, Montano MM, Katzenellenbogen BS. Identification of multiple, widely spaced estrogen-response regions in the rat progesterone receptor gene. Mol Endocrinol. 1994;8:952-969.
39. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest. 1996;97:403-412.
40. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
41. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
42. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation. 1993;88:2451-2454.
43. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension. 1995;25:848-853.